What is the effect of sodium dithionite (sickle solubility assay) on hemoglobin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sodium Dithionite in Sickle Solubility Assay

The sodium dithionite in the sickle solubility test reduces hemoglobins, making sickling hemoglobins (HbS) insoluble while normal hemoglobins remain soluble. 1

Mechanism of Action

Sodium dithionite functions as a reducing agent in the sickle solubility assay, which is a key diagnostic test used to detect the presence of HbS. The test works through the following mechanism:

  • Sodium dithionite reduces hemoglobin molecules by removing oxygen
  • When HbS is deoxygenated, it polymerizes and becomes insoluble
  • Normal hemoglobin (HbA) remains soluble even when deoxygenated
  • The insoluble HbS creates turbidity in the test solution, indicating a positive result

This chemical property allows laboratories to quickly identify the presence of HbS in patient samples as part of hemoglobinopathy screening protocols 1.

Clinical Application

The sickle solubility test is commonly used in hospital laboratories as part of screening algorithms for sickle cell disease:

  • It serves as a rapid initial test to detect the presence of HbS
  • A positive result indicates the presence of HbS but cannot differentiate between:
    • Homozygous sickle cell disease (HbSS)
    • Heterozygous sickle cell trait (HbAS)
    • Compound heterozygous states (e.g., HbSC, HbS-beta thalassemia)

Therefore, a positive sickle solubility test typically triggers further testing with more definitive methods such as:

  • High-performance liquid chromatography
  • Capillary electrophoresis
  • Mass spectrometry
  • Gel electrophoresis 1

Important Limitations

The sickle solubility test has several important limitations that clinicians should be aware of:

  • It cannot differentiate between sickle cell disease and sickle cell trait
  • False negative results can occur in:
    • Neonates (due to high levels of fetal hemoglobin)
    • Heavily transfused patients (due to dilution with donor HbA)
  • Should not be used in isolation for diagnosis 1

Chemical Properties

At the molecular level, sodium dithionite (Na₂S₂O₄) binds to deoxygenated hemoglobin at specific sites:

  • The binding occurs at the interface between hemoglobin molecules
  • Key residues involved include His116 and His117 of the beta subunit and Lys16 of the alpha subunit 2

This specific interaction with hemoglobin facilitates the reduction process that is essential for the sickle solubility test to function properly.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.